Giorgio Attardo

2.1k total citations
38 papers, 1.5k citations indexed

About

Giorgio Attardo is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Giorgio Attardo has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 14 papers in Molecular Biology and 11 papers in Pharmacology. Recurrent topics in Giorgio Attardo's work include Synthesis and Biological Activity (7 papers), HIV/AIDS drug development and treatment (6 papers) and Synthesis of Organic Compounds (6 papers). Giorgio Attardo is often cited by papers focused on Synthesis and Biological Activity (7 papers), HIV/AIDS drug development and treatment (6 papers) and Synthesis of Organic Compounds (6 papers). Giorgio Attardo collaborates with scholars based in Canada, United States and France. Giorgio Attardo's co-authors include Henriette Gourdeau, Songchun Jiang, John Drewe, Sui Xiong Cai, William Kemnitzer, Candace Crogan‐Grundy, Shailaja Kasibhatla, Serge Lamothe, Ben Tseng and Sasmita Tripathy and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Blood.

In The Last Decade

Giorgio Attardo

37 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giorgio Attardo Canada 17 890 477 349 185 112 38 1.5k
Michio Ichimura Japan 23 594 0.7× 928 1.9× 296 0.8× 264 1.4× 66 0.6× 49 1.6k
Anthony J. Roecker United States 20 881 1.0× 748 1.6× 280 0.8× 127 0.7× 48 0.4× 28 2.2k
Shin‐ichi Tsukamoto Japan 22 652 0.7× 765 1.6× 123 0.4× 119 0.6× 88 0.8× 71 1.6k
Ashraf Khalil Qatar 17 340 0.4× 641 1.3× 163 0.5× 113 0.6× 81 0.7× 37 1.2k
Sergey E. Tkachenko Russia 22 772 0.9× 880 1.8× 170 0.5× 170 0.9× 52 0.5× 71 1.9k
Alexander S. Kiselyov United States 26 1.5k 1.6× 1.1k 2.3× 165 0.5× 85 0.5× 46 0.4× 101 2.5k
Mohammed A. Kashem United States 25 301 0.3× 858 1.8× 267 0.8× 456 2.5× 170 1.5× 58 1.8k
John M. Humphrey United States 21 1.7k 1.9× 1.6k 3.4× 302 0.9× 249 1.3× 65 0.6× 36 2.6k
Adrianus M. C. H. van den Nieuwendijk Netherlands 19 738 0.8× 848 1.8× 160 0.5× 75 0.4× 176 1.6× 42 1.4k
Armand B. Cognetta United States 15 324 0.4× 728 1.5× 312 0.9× 107 0.6× 119 1.1× 15 1.2k

Countries citing papers authored by Giorgio Attardo

Since Specialization
Citations

This map shows the geographic impact of Giorgio Attardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giorgio Attardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giorgio Attardo more than expected).

Fields of papers citing papers by Giorgio Attardo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giorgio Attardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giorgio Attardo. The network helps show where Giorgio Attardo may publish in the future.

Co-authorship network of co-authors of Giorgio Attardo

This figure shows the co-authorship network connecting the top 25 collaborators of Giorgio Attardo. A scholar is included among the top collaborators of Giorgio Attardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giorgio Attardo. Giorgio Attardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Templin, Andrew T., Daniel T. Meier, Tami Wolden‐Hanson, et al.. (2018). Use of the PET ligand florbetapir for in vivo imaging of pancreatic islet amyloid deposits in hIAPP transgenic mice. Diabetologia. 61(10). 2215–2224. 8 indexed citations
2.
Attardo, Giorgio, Kelly A. Conway, Jason Goodman, et al.. (2017). [O1–08–06]: AN UPDATE ON THE BINDING PROFILE OF FLORTAUCIPIR IN AD VERSUS NORMAL CNS PROTEINS AND NORMAL BRAIN. Alzheimer s & Dementia. 13(7S_Part_4). 1 indexed citations
3.
4.
Gagnon, Martin, Marc J. Bergeron, Annie Castonguay, et al.. (2013). Chloride extrusion enhancers as novel therapeutics for neurological diseases. Nature Medicine. 19(11). 1524–1528. 246 indexed citations
5.
Kemnitzer, William, Songchun Jiang, Hong Zhang, et al.. (2008). Discovery of 4-aryl-2-oxo-2H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. Bioorganic & Medicinal Chemistry Letters. 18(20). 5571–5575. 70 indexed citations
6.
Kemnitzer, William, Songchun Jiang, Yan Wang, et al.. (2007). Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based HTS assay. Part 5: Modifications of the 2- and 3-positions. Bioorganic & Medicinal Chemistry Letters. 18(2). 603–607. 89 indexed citations
7.
Kemnitzer, William, Shailaja Kasibhatla, Songchun Jiang, et al.. (2005). Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure–activity relationships of the 7- and 5-, 6-, 8-positions. Bioorganic & Medicinal Chemistry Letters. 15(21). 4745–4751. 252 indexed citations
8.
Meerovitch, Karen, et al.. (2003). Thiophene‐Based Vitronectin Receptor Antagonists. ChemInform. 34(21). 1 indexed citations
9.
Meerovitch, Karen, et al.. (2003). Thiophene-based vitronectin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(3). 503–506. 9 indexed citations
10.
Meerovitch, Karen, Lorraine Leblond, Brigitte Grouix, et al.. (2003). A novel RGD antagonist that targets both αvβ3 and α5β1 induces apoptosis of angiogenic endothelial cells on type I collagen. Vascular Pharmacology. 40(2). 77–89. 63 indexed citations
11.
Denisov, Alexei Yu., Murthy S.R. Madiraju, Gang Chen, et al.. (2003). Solution Structure of Human BCL-w. Journal of Biological Chemistry. 278(23). 21124–21128. 93 indexed citations
12.
Gourdeau, Henriette, Philippe Genne, Salam Kadhim, et al.. (2002). Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts. Cancer Chemotherapy and Pharmacology. 50(6). 490–496. 12 indexed citations
13.
Rej, Rabindra, et al.. (2002). Novel nucleotide phosphonate analogues with potent antitumor activity. Bioorganic & Medicinal Chemistry Letters. 12(21). 3063–3066. 29 indexed citations
14.
Leblond, Lorraine, Giorgio Attardo, Bettina A. Hamelin, et al.. (2002). BCH-1868 [(-)-2-R-dihydroxyphosphinoyl-5-(S)-(guanin-9'-yl-methyl) tetrahydrofuran]: a cyclic nucleoside phosphonate with antitumor activity.. PubMed. 1(9). 737–46. 11 indexed citations
15.
16.
Wang, Wuyi, et al.. (1998). Dehydrogenation by air: Preparation of 1,3-disubstituted-5,1-dioxo-5,10-dihydro-1H-benzo[g] isochromene scaffold. Tetrahedron Letters. 39(17). 2459–2462. 17 indexed citations
17.
Wang, Wuyi, et al.. (1997). Synthetic Study of Selective Benzylic Oxidation. The Journal of Organic Chemistry. 62(19). 6598–6602. 37 indexed citations
18.
Xu, Yao‐Chang, et al.. (1994). DDQ-Induced, Anomeric Specific, and Diastereoselective Benzylic Glycosidation: A Novel Approach to Heterocyclic Anthracycline Antibiotics. The Journal of Organic Chemistry. 59(17). 4868–4874. 14 indexed citations
19.
Xu, Yao‐Chang, et al.. (1994). A Facile Synthesis of 3-Substituted Isothiochroman. Synthesis. 1994(4). 363–365. 5 indexed citations
20.
Kraus, Jean‐Louis & Giorgio Attardo. (1991). Synthesis of New 2,5-Substituted 1,3-Oxathiolanes. Intermediates in Nucleoside Chemistry. Synthesis. 1991(11). 1046–1048. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michio Ichimura Breakdown of academic impact, for papers by Anthony J. Roecker Breakdown of academic impact, for papers by Shin‐ichi Tsukamoto Breakdown of academic impact, for papers by Ashraf Khalil Breakdown of academic impact, for papers by Sergey E. Tkachenko Breakdown of academic impact, for papers by Alexander S. Kiselyov Breakdown of academic impact, for papers by Mohammed A. Kashem Breakdown of academic impact, for papers by John M. Humphrey Breakdown of academic impact, for papers by Adrianus M. C. H. van den Nieuwendijk Breakdown of academic impact, for papers by Armand B. Cognetta
Rankless by CCL
2026